AT313468B - Verfahren zur Herstellung von entzündungshemmend wirkenden Komplexen - Google Patents
Verfahren zur Herstellung von entzündungshemmend wirkenden KomplexenInfo
- Publication number
- AT313468B AT313468B AT990271A AT990271A AT313468B AT 313468 B AT313468 B AT 313468B AT 990271 A AT990271 A AT 990271A AT 990271 A AT990271 A AT 990271A AT 313468 B AT313468 B AT 313468B
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- complexes
- inflammatory
- inflammatory complexes
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8999970A | 1970-11-16 | 1970-11-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT313468B true AT313468B (de) | 1974-02-25 |
Family
ID=22220596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT990271A AT313468B (de) | 1970-11-16 | 1971-11-16 | Verfahren zur Herstellung von entzündungshemmend wirkenden Komplexen |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT313468B (en:Method) |
| AU (1) | AU461558B2 (en:Method) |
| BE (1) | BE775255A (en:Method) |
| BR (1) | BR7107569D0 (en:Method) |
| CA (1) | CA994241A (en:Method) |
| CH (1) | CH557177A (en:Method) |
| DE (1) | DE2156915A1 (en:Method) |
| DK (1) | DK132485C (en:Method) |
| ES (2) | ES397035A1 (en:Method) |
| FI (1) | FI51048C (en:Method) |
| FR (1) | FR2113976B1 (en:Method) |
| GB (1) | GB1345358A (en:Method) |
| IE (1) | IE36030B1 (en:Method) |
| IL (1) | IL38003A (en:Method) |
| NL (1) | NL7115198A (en:Method) |
| ZA (1) | ZA717652B (en:Method) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1335259C (en) * | 1989-03-31 | 1995-04-18 | Makoto Machida | Composition of spent liquor from pulping process for antiviral medicine |
-
1971
- 1971-10-25 IL IL38003A patent/IL38003A/xx unknown
- 1971-10-25 AU AU34928/71A patent/AU461558B2/en not_active Expired
- 1971-11-04 NL NL7115198A patent/NL7115198A/xx unknown
- 1971-11-08 GB GB5172671A patent/GB1345358A/en not_active Expired
- 1971-11-09 IE IE1414/71A patent/IE36030B1/xx unknown
- 1971-11-11 DK DK552471A patent/DK132485C/da active
- 1971-11-12 BR BR007569/71A patent/BR7107569D0/pt unknown
- 1971-11-12 BE BE775255A patent/BE775255A/xx unknown
- 1971-11-15 ES ES397035A patent/ES397035A1/es not_active Expired
- 1971-11-15 ZA ZA717652A patent/ZA717652B/xx unknown
- 1971-11-15 FI FI713261A patent/FI51048C/fi active
- 1971-11-15 CH CH1655371A patent/CH557177A/fr not_active IP Right Cessation
- 1971-11-15 FR FR7140790A patent/FR2113976B1/fr not_active Expired
- 1971-11-15 CA CA127,705A patent/CA994241A/en not_active Expired
- 1971-11-16 DE DE19712156915 patent/DE2156915A1/de active Pending
- 1971-11-16 AT AT990271A patent/AT313468B/de not_active IP Right Cessation
-
1974
- 1974-01-16 ES ES422331A patent/ES422331A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI51048B (en:Method) | 1976-06-30 |
| ES422331A1 (es) | 1976-06-01 |
| IL38003A (en) | 1974-06-30 |
| DE2156915A1 (de) | 1972-05-31 |
| ES397035A1 (es) | 1975-03-01 |
| NL7115198A (en:Method) | 1972-05-18 |
| DK132485B (da) | 1975-12-15 |
| ZA717652B (en) | 1972-10-25 |
| IE36030B1 (en) | 1976-08-04 |
| DK132485C (da) | 1976-05-17 |
| FI51048C (fi) | 1976-10-11 |
| CH557177A (fr) | 1974-12-31 |
| GB1345358A (en) | 1974-01-30 |
| FR2113976A1 (en:Method) | 1972-06-30 |
| CA994241A (en) | 1976-08-03 |
| AU461558B2 (en) | 1975-05-29 |
| FR2113976B1 (en:Method) | 1975-10-31 |
| IL38003A0 (en) | 1971-12-29 |
| IE36030L (en) | 1972-05-16 |
| BE775255A (fr) | 1972-03-01 |
| AU3492871A (en) | 1973-05-03 |
| BR7107569D0 (pt) | 1973-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT308105B (de) | Verfahren zur Herstellung von Dibenzylaminofluoranverbindungen | |
| CH527194A (de) | Verfahren zur Herstellung von Isochinolin-Derivaten | |
| AT320144B (de) | Verfahren zur Herstellung von 7-Amino-3-methyl-3-cephem-4-carbonsäuren | |
| AT306238B (de) | Verfahren zur Herstellung von neuen 3-Formylcephalosporinsulfoxyden | |
| AT313912B (de) | Verfahren zur Herstellung von Azetidinonen-(2) | |
| AT313471B (de) | Verfahren zur Herstellung von 7-Halogen-7-deoxy-lincomycinen | |
| CH520130A (de) | Verfahren zur Herstellung von N-Fluordichlormethylthio-sulfamidsäure-Derivaten | |
| AT304545B (de) | Verfahren zur Herstellung von neuen Nitrofuryl-triazolo-pyrimidinen | |
| AT310714B (de) | Verfahren zur Herstellung von 4-Oxocapronitril | |
| AT306922B (de) | Verfahren zur Herstellung von Erythromycylaminverbindungen | |
| AT305230B (de) | Verfahren zur Herstellung von 2-Äthylhexanal-(1) | |
| AT322732B (de) | Verfahren zur herstellung von 7-aminocephalosporansäuren | |
| AT306260B (de) | Verfahren zur Herstellung von neuen 3-Amino-cardenoliden | |
| AT310960B (de) | Verfahren zur Herstellung von 6α-Methyl-19-nor-pregnenen | |
| AT306235B (de) | Verfahren zur Herstellung von Erythromycylaminverbindungen | |
| AT333963B (de) | Verfahren zur herstellung von anasthesierend wirkenden injizierbaren zubereitungen | |
| AT332970B (de) | Verfahren zur herstellung von alkalipolyphosphatkomplexen von alpha -6-desoxy-5- hydroxytetracyclin | |
| AT306032B (de) | Verfahren zur Herstellung von 4-Hydroxy-6-halogenmethyl-pyrimidinen | |
| CH545305A (de) | Verfahren zur Herstellung von neuen 3-Guanidinoalkylthiophenen | |
| AT315143B (de) | Verfahren zur Herstellung von Cyclopropylmethylalkylaminen | |
| AT314506B (de) | Verfahren zur Herstellung von 4-Hydroxyphenylglycin | |
| AT304483B (de) | Verfahren zur Herstellung von Alkylphthalsäuren | |
| CH528496A (de) | Verfahren zur Herstellung von 21-Fluorsteroiden | |
| AT299945B (de) | Verfahren zur Herstellung von neuen Isoxazolyläthyl-tetrahydropyranolen | |
| AT310360B (de) | Verfahren zur Herstellung von 14-Anhydrobufalin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |